Three Beneficiaries of China's Healthcare Reform [View article]
One of the main goal of Chinese health care reform is to cut down over prescription of medicine in China. The main source of income in clinics and hospitals is the profit from selling excessive quantity of drugs to patients. If reform is successful, sell of drugs will drop precipitously. I emphasize again that universal health insurance is not even mentioned in the reform.
China Biotech Week in Review: Deals and Drugs [View article]
The first cholesterol-lowering statin, levostatin, is derived from Chinese Red-rice. Merck obtained the patent right, but had to compete with inexpensive Chinese red rice capsule, which led them to pursue the second statin, "Zocor". I am not surprised to see that Chinese red rice capsules are beneficial to heart disease patients.
Three Beneficiaries of China's Healthcare Reform [View article]
Three Beneficiaries of China's Healthcare Reform [View article]
China Biotech Week in Review: Deals and Drugs [View article]